Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia.

Saved in:
Bibliographic Details
Title: Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia.
Authors: Carratt SA; Oregon Health & Science University, Portland, OR, USA., Braun TP; Oregon Health & Science University, Portland, OR, USA., Coblentz C; Oregon Health & Science University, Portland, OR, USA., Schonrock Z; Oregon Health & Science University, Portland, OR, USA., Callahan R; Oregon Health & Science University, Portland, OR, USA., Curtiss BM; Oregon Health & Science University, Portland, OR, USA., Maloney L; Oregon Health & Science University, Portland, OR, USA., Foley AC; Oregon Health & Science University, Portland, OR, USA., Maxson JE; Oregon Health & Science University, Portland, OR, USA. maxsonj@ohsu.edu.
Source: Leukemia [Leukemia] 2021 Dec; Vol. 35 (12), pp. 3594-3599. Date of Electronic Publication: 2021 May 17.
Publication Type: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5551
DOI:10.1038/s41375-021-01278-2